Underlying histological activity of hepatitis plays an important role for tumor recurrence after curative resection of hepatocellular carcinoma

Acta Medica Nagasakiensia

Volumn 53, Issue 4, 2008, Pages 97-104

  Kobayashi, Kazuma ^a   Fujioka, Hikaru ^b   Kamohara, Yukio ^c   Okudaira, Sadayuki ^a   Yanaga, Katsuhiko ^c   Furui, Junichiro ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Early and late recurrence; Grading; Hepatocellular carcinoma; HPF; Staging

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; FEMALE; FIBROSIS; HEPATITIS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; TUMOR RECURRENCE;

EID: 66149192559     PISSN: 00016055     EISSN: 00016055     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Shimada K, Sakamoto Y, Esaki M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 14: 2337-2347, 2007 (Pubitemid 47174918)
2. Kim BW, Kim YB, Wang HJ, Kim MW. Risk factors for immediate postoperative fatal recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 7: 99-104, 2006
3. Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes. Surgery 141: 330-339, 2007
4. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after curative resection of hepatocellular carcinoma. Cancer 89: 500-507, 2000 (Pubitemid 30640096)
5. Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 205: 27-36, 2007 (Pubitemid 47016970)
6. Matsumoto K, Yoshimoto J, Sugo H, Kojima K, Futagawa S, Matsumoto T. Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Heptol Res 23: 196-201, 2002 (Pubitemid 36104398)
7. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200-207, 2003 (Pubitemid 36169630)
8. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202: 275-283, 2006 (Pubitemid 43112487)
9. Tarao K, Takemiya S, Tamai S, et al. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 79: 688-694, 1997 (Pubitemid 27076334)
10. Koike Y, Shiratori Y, Sato S, et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - an analysis of 236 consecutive patients with a single lesion. Hepatology 32: 1216-1223, 2000
11. Shuto T, Hirohashi K, Wakasa K, Ikebe T, Kinoshita H. Hyperplastic foci as a prognostic factor after resection of hepatocellular carcinoma. Hepatogastroenterology 46: 2439-2441, 1999 (Pubitemid 29454117)
12. The Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo: Kanehara & Co., Ltd, 2000
13. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435, 1981
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheure P. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520, 1994 (Pubitemid 24166476)
15. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31: 241-246, 2000
16. Kato K, Ozaki D, Zheng K, et al. Characterization of hyperplastic foci observed in surgical specimens of hepatocellular carcinoma. Pathol Int 51:20-25, 2001 (Pubitemid 32158807)
17. Adachi E, Maeda T, Matsumata T, et al. Risks factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108: 768-775, 1995
18. Kamiyama T, Takahashi M, Nakagawa T, et al. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Sur 244: 451-463, 2006 (Pubitemid 44273587)
19. Furihata T, Sawada T, Kita J, et al. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterol 55: 1705-1709, 2008
20. Zou WL, Zang YJ, Chen XG, Shen ZY. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Hepatobiliary Pancreas Dis Int 7: 145-151, 2008
21. Shirabe K, Takenaka K, Taketomi A, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 77: 1050-1055, 1996 (Pubitemid 26080893)
22. Volpes R, van den Oord JJ, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 15: 262-275, 1992
23. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 264: 1303-1306, 1989
24. Wakasa K, Haba T, Sasaki M, et al. Hyperplastic foci in chronic liver disease: Their proliferative activity assessed by nucleolar organizing region. Pathol Intl 48: 29-32, 1998